Friday, August 14, 2020 8:16:39 AM
I'm really confused here. What is different about this August 14th PR compared to the June 8th PR. They expanded the trial back then to non-vent patients. Can somebody tell me what I'm missing?
https://relieftherapeutics.com/relief-therapeutics-and-neurorx-expand-clinical-trial-of-rlf-100-to-all-patients-with-critical-covid-19-and-respiratory-failure/
https://relieftherapeutics.com/relief-therapeutics-and-neurorx-expand-clinical-trial-of-rlf-100-to-all-patients-with-critical-covid-19-and-respiratory-failure/
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
